Brief: Shanghai Heartcare Medical Technology Posts FY Net Loss Attributable Of RMB197.9 Million
28/03/2022 16:21
March 28 (Reuters) - Shanghai HeartCare Medical Technology
Corp Ltd 6609.HK :
* NET LOSS ATTRIBUTABLE FOR YEAR RMB197.9 MILLION
* FY REVENUE AMOUNTED TO ABOUT RMB90.1 MILLION, REPRESENTING
AN
INCREASE OF 517%
Source text for Eikon: ID:nHKSc0b5DQ
Further company coverage: 6609.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai HeartCare Medical Technology
See all newsBrief: Shanghai Heartcare Medical Technology Says Board Did Not Declare Payment Of An Interim Dividend
China's HeartCare Medical H1 revenue surges on stroke segment growth
Brief: Shanghai Heartcare Medical Technology Expects HY Revenue Of No Less Than Rmb280 Million
Brief: Shanghai Heartcare Medical Technology Approves H Share Repurchase Plan Up To HKD100 Million For Up To 1 Million H Shares
Brief: Shanghai HeartCare Medical Technology Sees FY PBT RMB80 Million